Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StickIt is an innovative Israeli biotechnology company specializing in the development of advanced delivery systems for cannabinoids and other active ingredients. The company's core technology is a proprietary, toothpick-shaped stick that contains a precise, standardized dose of cannabis extracts and terpenes, designed to be inserted into any cigarette or pre-roll. This delivery method ensures consistent dosing and a controlled experience, addressing the variability often found in traditional medical cannabis consumption. Beyond cannabis, StickIt is adapting its platform for nicotine replacement therapies and functional nutraceuticals. The company is focused on global expansion through licensing and joint ventures, targeting markets that require precise and discreet delivery of active compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StickIt Labs.